ArticleOncology letters2026

METTL5 reprograms glycolytic metabolism and promotes non-small cell lung cancer progression by modifying PGAM1.

Yuchen Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.